In 2020 the World Health Organization launched the “Guidance for post-market surveillance and market surveillance of medical devices, including in vitro diagnostics”.
According to WHO, the document brings out a series of activities to be conducted by manufacturers ” to collect and evaluate experience gained from medical devices that have been placed on the market, and to identify the need to take any action.”

Read the document:

REGULATORY COALITION PRINCIPAL MEMBERS